Scientific barriers make effective transdermal delivery of GLP-1 challenging
It is generally not recommended for long-term use due to several factors, including its known potential for dependence and addiction, the discomfort and challenge of managing withdrawal symptoms, the development of tolerance with prolonged use, its sedative effects, and the potential for drug interactions
More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Drugs.com Podcast Subscribe to our newsletter Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
This condition affects approximately one in three adults in the UK and exists in two main forms: non-alcoholic fatty liver disease (NAFLD) , which develops in people who drink little or no alcohol, and alcohol-related liver disease (ARLD) , caused by excessive alcohol consumption